Patent ID: 11938185
Assignee: H. LUNDBECK A/S
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G  Y | IPC A  C  G

Claim 39:
40. The method of claim 3, wherein the humanized anti-Pituitary Adenylate Cyclase-Activating Polypeptide (“PACAP”) antibody or antigen binding fragment thereof comprises a heavy chain variable region polypeptide having at least 95% identity to SEQ ID NO: 1322 and a light chain variable region polypeptide having at least 95% identity to SEQ ID NO: 1342,
wherein said heavy chain variable region comprises the heavy chain complementarity-determining region (CDR) 1 polypeptide of SEQ ID NO: 1324, the heavy chain CDR2 polypeptide of SEQ ID NO: 1326, and the heavy chain CDR3 polypeptide of SEQ ID NO: 1328, and
said light chain variable region comprises the light chain CDR1 polypeptide of SEQ ID NO: 1344, the light chain CDR2 polypeptide of SEQ ID NO: 1346, and the light chain CDR3 polypeptide of SEQ ID NO: 1348.